Novadaq to present at BMO Healthcare ...( TORONTO Nov. 28 / Novadaq(R) Tech...),Health

TORONTO, Nov. 28 /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc. (TSX: NDQ), a developer of real-time medical imaging systems and image guided therapies for the operating room, today announced that Dr. Arun Menawat, President & CEO of Novadaq, will present the corporate story, technology and highlights, including an update on commercial development and the pipeline, at the BMO Focus on Healthcare Conference. The conference runs from Tuesday, December 4 through Wednesday, December 5 at the Millenium Broadway Hotel in New York.

Dr. Menawat's presentation is at 1:30 p.m. ET on Wednesday, December 5 and will be webcast live from Novadaq's website at http://www.novadaq.com.

About Novadaq Technologies

Novadaq Technologies Inc. (TSX: NDQ) develops and commercializes medical imaging systems and real-time image guided therapies for use in the operating room. Novadaq's proprietary ICG imaging systems can be used to visualize blood vessels, nerves and the lymphatic system during a variety of surgical procedures. Novadaq's SPY(R) Imaging System, commercially available worldwide, enables cardiac surgeons to visually assess coronary vasculature and bypass graft functionality during the course of heart bypass surgery. The SPY System is expandable to include upgrade kits for use during other surgeries such as plastic, reconstructive and organ transplant surgery allowing surgeons to evaluate blood flow and tissue and organ perfusion. In addition, SPY is ideal for use during urological procedures enabling surgeons to visualize vessels, tumors, the lymphatic system and potentially nerve bundles. Novadaq's OPTTX(R) System is aimed at the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD) by using the same core imaging technology that is used in the SPY Imaging System. Novadaq also offers the FDA approved PINPOINT(TM) endoscopic system for visualizing native tissue fluores
'/>"/>